BioAge Labs (BIOA) Total Non-Current Liabilities (2023 - 2026)

BioAge Labs has disclosed Total Non-Current Liabilities across 4 years of filings, most recently posting $18.1 million for Q1 2026.

• Total Non-Current Liabilities for Q1 2026 came in at $18.1 million, down 40.95% year-over-year; the trailing twelve-month figure through Mar 2026 was $18.1 million (down 40.95% YoY), and the FY2025 annual result was $22.5 million, down 35.72% from the prior year.
• Total Non-Current Liabilities came in at $18.1 million for Q1 2026 at BioAge Labs, down from $22.5 million in the prior quarter.
• In the past five years, Total Non-Current Liabilities ranged from a high of $66.4 million in Q4 2023 to a low of $18.1 million in Q1 2026.
• The 4-year median for Total Non-Current Liabilities is $27.4 million (2025), against an average of $31.3 million.
• Across the five-year window, Total Non-Current Liabilities plunged 47.34% in 2024 and advanced 19.36% in 2025, its largest moves.
• BioAge Labs' Total Non-Current Liabilities stood at $66.4 million in 2023, then slumped by 47.34% to $35.0 million in 2024, then plunged by 35.72% to $22.5 million in 2025, then declined by 19.64% to $18.1 million in 2026.
• The last three Total Non-Current Liabilities figures came in at $18.1 million (Q1 2026), $22.5 million (Q4 2025), and $27.5 million (Q3 2025), per Business Quant data.